What is the recommended dosing frequency for iron dextran (iron dextran) administration in a patient with severe iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Dextran Dosing for Severe Iron Deficiency Anemia

For severe iron deficiency anemia, iron dextran should be administered as a weekly regimen of 100 mg IV over 5 minutes for 10 doses to achieve a total dose of 1 gram, or as a total dose infusion given over several hours. 1

Administration Protocol

Initial Test Dose

  • Prior to initiating IV iron dextran therapy, a one-time test dose of 25 mg should be given IV and patient observed for 1 hour before administering the main dose 2, 1
  • For pediatric patients weighing <10 kg, the test dose should be 10 mg; for those weighing 10-20 kg, the test dose should be 15 mg 2
  • Iron dextran should be administered by slow IV push at a rate not exceeding 1.0 mL (50 mg, if undiluted) per minute 2

Dosing Options

  • Option 1: Weekly dosing regimen - 100 mg IV over 5 minutes once weekly for 10 doses to achieve a total dose of 1 gram 1
  • Option 2: Total dose infusion - Single doses of 500-1000 mg diluted in 250 mL normal saline infused over 1 hour 1, 3
  • For patients with chronic kidney disease on home hemodialysis or peritoneal dialysis, single doses of 500-1000 mg can be administered 1

Monitoring Parameters

  • Monitor iron status by measuring transferrin saturation (TSAT) and serum ferritin at least once every 3 months 2, 1
  • Target iron parameters: TSAT ≥20% and serum ferritin ≥100 ng/mL 2, 1
  • Avoid measuring iron parameters within 7-14 days after IV iron administration for accurate results 1
  • The goal of iron therapy is to improve erythropoiesis, not just to attain specific levels of TSAT and/or serum ferritin 2

Safety Considerations

  • Acute adverse reactions may occur with administration of IV iron dextran, including anaphylaxis-like reactions in fewer than 1% of administrations 2
  • Common adverse events include hypotension, hypertension, nausea, vomiting, diarrhea, pain, fever, dyspnea, pruritus, headaches, and dizziness 1
  • A history of multiple drug allergies is associated with increased risk of an acute iron dextran reaction 2
  • Have emergency medications (epinephrine, diphenhydramine, corticosteroids) readily available during administration 2, 4

Special Considerations

  • For patients who cannot tolerate oral iron due to gastrointestinal symptoms or inadequate response, IV iron dextran is an effective alternative 5
  • Research shows that 500 mg/week for 2 weeks can be as effective and safe as 200 mg/week for 5 weeks, and more cost-effective 3
  • Response to therapy is typically faster in patients who have been severely anemic for prolonged periods 6
  • Avoid iron administration in patients with active infection 1
  • To prevent iron overload, temporarily withhold IV iron if TSAT exceeds 50% or serum ferritin exceeds 800 ng/mL 2, 7

References

Guideline

IV Iron Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous iron dextran treatment in predialysis patients with chronic renal failure.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000

Research

Clinical use of the total dose intravenous infusion of iron dextran.

The Journal of laboratory and clinical medicine, 1988

Research

Intravenous iron-dextran in the treatment of iron deficient anemia.

Journal of the National Medical Association, 1979

Research

Strategies for iron supplementation: oral versus intravenous.

Kidney international. Supplement, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.